Revealed autophagy mechanism is potential dementia target
A study has discovered the regulating process behind cell autophagy which could aid in the development of neurodegenerative disease treatments.
List view / Grid view
A study has discovered the regulating process behind cell autophagy which could aid in the development of neurodegenerative disease treatments.
A new drug target for treating glioblastoma has been identified from a cellular pathway found to contribute to the spread of glioma stem cells.
Researchers have found that the presence of microglia brain cells allowed plaques to form in the brains of rodents, leading to Alzheimer’s disease.
A new study from the University of Eastern Finland has shown that peripheral T helper cells may have a role in the development of type 1 diabetes.
A new study has shown that mutations in mitochondrial DNA induced by cell reprogramming may trigger an immune response.
A study has revealed a drug target for skin cancers which regulates the differentiation of cells and the roles they conduct in the body.
Researchers have revealed a key inflammation mechanism that contributes to melanoma brain metastasis and could be a therapeutic target.
A new platform has enabled an unprecedented level of control over individual molecules and particles on a chip for high-throughput analysis.
A new study has revealed that M. tuberculosis uses a unique type of antacid which gives immune cells indigestion, enabling the bacteria to survive.
A study has discovered a pathway that allows the enterovirus to successfully infect cells and promote genome release which could be a therapeutic target.
A new study has identified possible regulators that determine differences in cancer tumours between genders.
Researchers have discovered electrical channels important in sensory cell renewal which could be studied further to develop therapies for retinal diseases.
Researchers have created a fruit fly model to investigate uric acid-related diseases such as diabetes to aid in drug development.
Researchers may have fundamentally altered the way scientists study brain diseases with new CRISPR technology.
A study has discovered a molecule key in neuronal growth that could be used as a drug target to treat anxiety-related diseases.